Literature DB >> 20963486

Oxidative damage in rat brain during aging: interplay between energy and metabolic key target proteins.

F Di Domenico1, M Perluigi, D A Butterfield, C Cornelius, V Calabrese.   

Abstract

Aging is characterized by a gradual and continuous loss of physiological functions and responses particularly marked in the central nervous system. Reactive oxygen species (ROS) can react with all major biological macromolecules such as carbohydrates, nucleic acids, lipids, and proteins. Since proteins are the major components of biological systems and regulate multiple cellular pathways, oxidative damage of key proteins are considered to be the principal molecular mechanisms leading to age-related deficits. Recent evidences support the notion that a decrease of energy metabolism in the brain contribute to neuronal loss and cognitive decline associated with aging. In the present study we identified selective protein targets which are oxidized in aged rats compared with adult rats. Most of the oxidatively modified proteins we found in the present study are key proteins involved in energy metabolism and ATP production. Oxidative modification of these proteins was associated with decreased enzyme activities. In addition, we also found decreased levels of thiol reducing system. Our study demonstrated that oxidative damage to specific proteins impairs energy metabolism and ATP production thus contributing to shift neuronal cells towards a more oxidized environment which ultimately might compromise multiple neuronal functions. These results further confirm that increased protein oxidation coupled with decreased reducing systems are characteristic hallmarks of aging and aging-related degenerative processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963486     DOI: 10.1007/s11064-010-0295-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  56 in total

1.  Protein oxidative damage.

Authors:  E Shacter
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Carbonyl modified proteins in cellular regulation, aging, and disease.

Authors:  Rodney L Levine
Journal:  Free Radic Biol Med       Date:  2002-05-01       Impact factor: 7.376

3.  Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure.

Authors:  P P Dzeja; K T Vitkevicius; M M Redfield; J C Burnett; A Terzic
Journal:  Circ Res       Date:  1999-05-28       Impact factor: 17.367

4.  Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer.

Authors:  Petras P Dzeja; Ryan Bortolon; Carmen Perez-Terzic; Ekshon L Holmuhamedov; Andre Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

Review 5.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

6.  Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction.

Authors:  M V Aksenova; M Y Aksenov; J M Carney; D A Butterfield
Journal:  Mech Ageing Dev       Date:  1998-01-30       Impact factor: 5.432

7.  Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol).

Authors:  B J Howard; S Yatin; K Hensley; K L Allen; J P Kelly; J Carney; D A Butterfield
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

8.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

9.  Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.

Authors:  H Fai Poon; Mark Frasier; Nathan Shreve; Vittorio Calabrese; Benjamin Wolozin; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2005-04       Impact factor: 5.996

10.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

View more
  13 in total

1.  Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes.

Authors:  V Calabrese; G Scapagnini; S Davinelli; G Koverech; A Koverech; C De Pasquale; A Trovato Salinaro; M Scuto; E J Calabrese; A R Genazzani
Journal:  J Cell Commun Signal       Date:  2014-11-09       Impact factor: 5.782

2.  Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.

Authors:  Jorge Galino; Montserrat Ruiz; Stéphane Fourcade; Agatha Schlüter; Jone López-Erauskin; Cristina Guilera; Mariona Jove; Alba Naudi; Elena García-Arumí; Antoni L Andreu; Anatoly A Starkov; Reinald Pamplona; Isidre Ferrer; Manuel Portero-Otin; Aurora Pujol
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

Review 3.  Effects of pH alterations on stress- and aging-induced protein phase separation.

Authors:  Xuejiao Jin; Min Zhou; Shuxin Chen; Danqi Li; Xiuling Cao; Beidong Liu
Journal:  Cell Mol Life Sci       Date:  2022-06-24       Impact factor: 9.207

Review 4.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

Review 5.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

6.  Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra.

Authors:  Adrian C Williams; Lisa J Hill; David B Ramsden
Journal:  Curr Gerontol Geriatr Res       Date:  2012-03-21

Review 7.  Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling.

Authors:  Carolin Cornelius; Guido Koverech; Rosalia Crupi; Rosanna Di Paola; Angela Koverech; Francesca Lodato; Maria Scuto; Angela T Salinaro; Salvatore Cuzzocrea; Edward J Calabrese; Vittorio Calabrese
Journal:  Front Pharmacol       Date:  2014-06-10       Impact factor: 5.810

8.  Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: Mitochondria as a "chi".

Authors:  Carolin Cornelius; Rosario Perrotta; Antonio Graziano; Edward J Calabrese; Vittorio Calabrese
Journal:  Immun Ageing       Date:  2013-04-25       Impact factor: 6.400

Review 9.  Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases.

Authors:  Andrzej Szutowicz; Hanna Bielarczyk; Agnieszka Jankowska-Kulawy; Tadeusz Pawełczyk; Anna Ronowska
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

10.  Effects of treating old rats with an aqueous Agaricus blazei extract on oxidative and functional parameters of the brain tissue and brain mitochondria.

Authors:  Anacharis B de Sá-Nakanishi; Andréia A Soares; Andrea Luiza de Oliveira; Jurandir Fernando Comar; Rosane M Peralta; Adelar Bracht
Journal:  Oxid Med Cell Longev       Date:  2014-04-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.